Have a personal or library account? Click to login
Mesenteric ischemia after capecitabine treatment in rectal cancer and resultant short bowel syndrome is not an absolute contraindication for radical oncological treatment Cover

Mesenteric ischemia after capecitabine treatment in rectal cancer and resultant short bowel syndrome is not an absolute contraindication for radical oncological treatment

Radiology and Oncology
Volume 49 (2015): Issue 2 (June 2015)
By: Ana Perpar,  Erik Brecelj,  Nada Rotovnik Kozjek,  Franc Anderluh,  Irena Oblak,  Marija Skoblar Vidmar and  Vaneja Velenik  
Open Access
|Mar 2015

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.2478/raon-2014-0024 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 181 - 184
Submitted on: Dec 10, 2013
|
Accepted on: Jan 23, 2014
|
Published on: Mar 25, 2015
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
rectal cancer,
capecitabine,
acute mesenteric ischemia,
multiorgan failure,
short bowel syndrome
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2015 Ana Perpar, Erik Brecelj, Nada Rotovnik Kozjek, Franc Anderluh, Irena Oblak, Marija Skoblar Vidmar, Vaneja Velenik, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 49 (2015): Issue 2 (June 2015)Next article